Lawmakers slip a win for pharma into federal spending package – STAT
In a win for pharma, Congress included a provision in the end-of-year spending package that would give certain drugs seven extra years of patent protection.
Related Articles
Nominee to be RFK Jr.’s second-in-command at HHS positions himself as ‘main street doctor’
Brian Christine, RFK Jr.’s HHS deputy pick, told senators he’ll prioritize chronic disease and patient care.
International consortium uncovers protein changes linked to neurodegenerative disease
And more health news stories of the day.
Protein structure competition, of AlphaFold fame, nearing deal to replace lost NIH funding
CASP, a popular research competition that spawned three Nobel laureates, is set to lose NIH funding.
Medicare proposes ‘efficiency’ pay cuts that would hit highly paid specialists the most
Medicare is proposing cuts to how much it pays doctors for many medical procedures, scans, and tests.
Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a “low tariff”
Medical school prerequisites should include microbiology
Medical schools must make microbiology a prerequisite — to prepare students not just for school but for practicing medicine.
Oncologists need to see antimicrobial resistance as a cancer care delivery crisis
Oncologists must join the global fight against microbial resistance.
Medicare proposes ‘efficiency’ pay cuts that would hit highly paid specialists the most
Medicare is proposing cuts to how much it pays doctors for many medical procedures, scans, and tests.
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.